subject area of
- An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation Academic Article
- Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter Academic Article
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management Academic Article
- Dronedarone for Atrial Fibrillation Academic Article
- Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter Academic Article
- Dronedarone in High-Risk Permanent Atrial Fibrillation Academic Article
- Dronedarone in patients with congestive heart failure: insights from ATHENA Academic Article
- Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation Academic Article
- Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial Academic Article
- Effects of Dronedarone on Clinical Outcomes in Patients with Lone Atrial Fibrillation: Pooled Post Hoc Analysis from the ATHENA/EURIDIS/ADONIS Studies Academic Article
- Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study Academic Article
- Interaction Between Digoxin and Dronedarone in the PALLAS Trial Academic Article
- Rationale and Design of ATHENA: A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in PatiENts with Atrial Fibrillation/Atrial Flutter Academic Article
- Rhythm- and Rate-Controlling Effects of Dronedarone in Patients With Atrial Fibrillation (from the ATHENA Trial) Academic Article